Altasciences
Chris became CEO of Altasciences in 2010. He began his career at Huntingdon Life Sciences in England in 1975 as a toxicologist. He served as Section Head for preclinical development at Beecham Pharmaceuticals, as COO for CTBR Bio-Research in Montreal and then as SVP for Charles River Laboratories, responsible for seven preclinical facilities in the U.S., Canada, and China.
This person is not in any offices
Altasciences
Your partner in seamless, end-to-end drug development, we act to get your most promising compounds into and through early phase clinical trials.